Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Caribou Biosciences (CRBU) has 3 years of Non-cash Items data on file, last reported at $5.6 million in Q2 2022.

• Quarterly Non-cash Items rose 8.25% year-over-year to $5.6 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $5.6 million (up 8.25% YoY) and the FY2021 annual result came in at $50.1 million, up 622.83% from the prior year.
• Non-cash Items climbed to $5.6 million in Q2 2022 per CRBU's latest filing, from $1.6 million in the prior quarter.
• Across five years, Non-cash Items topped out at $50.1 million in Q4 2021 and bottomed at $1.6 million in Q1 2022.
• The 3-year median for Non-cash Items is $6.9 million (2020), against an average of $12.3 million.
• The widest annual swing landed in 2021, when Non-cash Items soared 622.83%; it then slumped 83.26% in 2022.
• Tracing CRBU's Non-cash Items over 3 years: stood at $6.9 million in 2020, then soared by 622.83% to $50.1 million in 2021, then sank by 88.72% to $5.6 million in 2022.
• Per Business Quant, the three latest CRBU Non-cash Items figures stand at $5.6 million (Q2 2022), $1.6 million (Q1 2022), and $50.1 million (Q4 2021).

Peer Comparison